Partner models consist of a healthcare institution operating a specialty pharmacy in partnership or in contract with another entity to offer the full range of services required for an accredited specialty pharmacy. Accreditation standards are a valuable resource to healthcare pharmacy leaders to ensure that all internal and partner specific regulatory components are in place.…
It is critical for any healthcare institution to understand the details of applicable laws and regulations to structure its approach to specialty pharmacy practices. The first step is to do a gap analysis of state and federal regulations pertaining to specialty pharmacy services. Risk Evaluation and Mitigation Strategies (REMS) requirements for specific products must also…
Specialty drugs are distinguished by two main characteristics: cost and complexity. Specialty drugs are expensive because of their delicate nature such as limited shelf life, need for climate-controlled shipping and meticulous storage. Specialty drugs are complex because they require special handling and services, inventory management and intense administration. They also need a high level of…
Lakewood, Colorado, November 7, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of substantially all of the assets (other than cash and accounts receivable) and certain liabilities of the cloud-based continuous monitoring (“CM”) business of FreshLoc Technologies, Inc., a Texas corporation (“FreshLoc”). CM systems are used…
Lakewood, Colorado, November 4, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of certain assets and liabilities of Mydent International Corp. (“Mydent”). Mesa previously provided biological indicator mail-in testing services (“Mail-In”) to Mydent under an original equipment manufacturer agreement. The acquisition is expected to add approximately…
Lakewood, Colorado, November 2, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted net income for the second quarter ended September 30, 2016. Highlights for the current quarter ended September 30, 2016 as compared to the same period last year: Revenues increased 12 percent Adjusted…
Lakewood, Colorado, October 4, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2016, to shareholders of record at the close of business…
Lakewood, Colorado September 15, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the release of ViewPoint®, a Continuous Monitoring System designed to provide an intuitive interface, deviation notifications, and complete on-demand reporting. Mesa’s ViewPoint System combines software, hardware, and expertise with innovative design and user-friendly features to make continuous…
Lakewood, Colorado, August 10, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of certain assets and liabilities of Rapid Aid Corp (“Rapid Aid”) by the Company’s subsidiary, Mesa Canada, Inc. (“Mesa Canada”). Rapid Aid was the Company’s exclusive supplier of cold chain packaging gel products (“CC…
Lakewood, Colorado, July 28, 2016 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported a 16 percent increase in revenues for the first quarter ended June 30, 2016. Revenues for the first quarter increased 16 percent to $21,114,000 as compared to $18,158,000 for the same quarter last year. Operating income…